T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells.
作者信息
Mihara K, Bhattacharyya J, Kitanaka A, Yanagihara K, Kubo T, Takei Y, Asaoku H, Takihara Y, Kimura A
出版信息
Leukemia. 2012 Feb;26(2):365-7. doi: 10.1038/leu.2011.205. Epub 2011 Aug 12.
PMID:21836610
Abstract
摘要
Zotero 插件